Laboratories at Children’s Hospital Boston to Use Protein Forest’s Digital ProteomeChip™ System
News Dec 12, 2008
Protein Forest™ has announced that Children’s Hospital Boston has recently installed the digital ProteomeChip™ System (dPC™) to use in a recently NIH funded study entitled “Multi-disciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network (U01) Discovery Site”.
This study will be carried out in the laboratories of Keith Solomon, PhD., Assistant Professor of Orthopedic Surgery at Harvard Medical School and Administrative Director of the Proteomics Center at Children’s Hospital Boston, Richard Lee, MD, Assistant Professor of Surgery (HMS), Marsha Moses, Professor of Surgery (HMS), and Director of the Vascular Biology Program (CHB), and the Proteomics Center at Children’s Hospital Boston, under the direction of Hanno Steen, Ph.D., Assistant Professor of Pathology and Systems Biology (HMS).
Dr. Solomon’s lab had been evaluating technologies to discover new biomarkers in urine and has selected the dPC system for this study. The ability to identify new potential biomarkers never before seen with other methods, the analysis and the ease of use were critical factors in selecting the dPC platform for this study.
The ProteomeChip system fractionates and concentrates proteins or peptides by parallel isoelectric focusing in 30 minutes for superior mass spec analysis. Additionally, pI information from the dPC prefractionation enables rapid discovery of post-translational modification based biomarkers.
Researchers say they have discovered a gene mutation that slows the metabolism of sugar in the gut, giving people who have the mutation a lower risk of diabetes, obesity, heart failure, and even death. The researchers say their finding could provide the basis for drug therapies that could mimic the workings of this gene mutation.
A computer-guided algorithm may help scientists find just the right spot to split a protein and then reassemble it to functionality, according to a new study. Researchers say this could be another step — perhaps even a dance step — toward using chemical and light signals to create new medical treatments and biosensors.READ MORE
5th International Congress on Epigenetics & Chromatin
Aug 22 - Aug 23, 2019